Edward Ashton - Concepedia

Author

Edward Ashton

Pfizer (United States)

Also Known As

Ashton, Edward, E Ashton, E. Ashton, E.A. Ashton, EDWARD A. ASHTON, Edward A Ashton, Edward A. Ashton, Edward Ashton

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Virtual High School University of Rochester The University of Texas MD Anderson Cancer Center United States Naval Research Laboratory

About

Edward Ashton is an author at Pfizer (United States) specializing in engineering, biomedical imaging, and image analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	232
2	Health Sciences	2	2	105
3	Computer Science	2	2	91
4	Medicine	1	1	34
5	Biostatistics	1	1	16

Edward Ashton

Publications

944

Citations

H-Index

Page 1

	Year	Citations
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study Glenn Liu, Hope S. Rugo, George Wilding, Journal of Clinical Oncology	2005	260
Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI Edward Ashton, Chihiro Takahashi, Michel J. Berg, Journal of Magnetic Resonance Imaging	2003	103
Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas Monica Mita, Matthew A. Spear, Lorrin Yee, Clinical Cancer Research	2010	102
Multiple Resolution Bayesian Segmentation of Ultrasound Images Edward Ashton, Kevin J. Parker Ultrasonic Imaging Image ReconstructionMedical UltrasoundEngineeringUltrasound ImagesDiagnostic Imaging	1995	89
Detection of subpixel anomalies in multispectral infrared imagery using an adaptive Bayesian classifier Edward Ashton IEEE Transactions on Geoscience and Remote Sensing Anomaly DetectionMachine LearningEngineeringMultispectral ImagingSubpixel Targets	1998	77
Scan‐rescan variability in perfusion assessment of tumors in MRI using both model and data‐derived arterial input functions Edward Ashton, David Raunig, Chaan S. Ng, Journal of Magnetic Resonance Imaging	2008	69
Reproducibility of Perfusion Parameters in Dynamic Contrast-Enhanced MRI of Lung and Liver Tumors: Effect on Estimates of Patient Sample Size in Clinical Trials and on Individual Patient Responses Chaan S. Ng, David Raunig, Edward F. Jackson, American Journal of Roentgenology	2010	59
Segmentation and Feature Extraction Techniques, with Applications to MRI Head Studies Edward Ashton, Michel J. Berg, Kevin J. Parker, Magnetic Resonance in Medicine	1995	43
A novel method for illumination suppression in hyperspectral images Edward Ashton, Brian D. Wemett, Robert A. Leathers, Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Image AnalysisEngineeringImaging SpectroscopySpectroscopySpectral Imaging	2008	36
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors Alejandro D. Ricart, Edward Ashton, Matthew M. Cooney, Cancer Chemotherapy and Pharmacology OncologyMedicinePathologyAdvanced Solid TumorsNovel Vascular-disrupting Agent	2011	34

Page 1